PCTAIRE2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-42688
Conjugate
Catalog #
Key Product Details
Validated by
Biological Validation
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation (Negative), Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1.0 mg/ml
Product Specifications
Immunogen
The immunogen for this product maps to a region between residue 1 and 50 of human PCTAIRE protein kinase 2 using the numbering given in entry NP_002586.2 (GeneID 5128).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PCTAIRE2 Antibody
Immunohistochemistry-Paraffin: PCTAIRE2 Antibody [NBP1-42688]
Immunohistochemistry-Paraffin: PCTAIRE2 Antibody [NBP1-42688] - Sample: FFPE section of human breast carcinoma (left) and kidney clear cell carcinoma (right). Antibody: Affinity purified rabbit anti- PCTAIRE 2 used at a dilution of 1:1,000 (1ug/ml). Detection: DABApplications for PCTAIRE2 Antibody
Application
Recommended Usage
Immunohistochemistry
1:500-1:2000
Immunohistochemistry-Paraffin
1:500-1:2000
Western Blot
1:2000-1:10000
Application Notes
Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: PCTAIRE2
Long Name
Cyclin-dependent kinase 17
Alternate Names
CDK17, PCTK2
Entrez Gene IDs
5128 (Human)
Gene Symbol
CDK17
Additional PCTAIRE2 Products
Product Documents for PCTAIRE2 Antibody
Product Specific Notices for PCTAIRE2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...